Corixa [CRXA] - cancer vaccines Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corixa [CRXA] - cancer vaccines

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (38)	1/3/2001 11:22:14 AM
From: Lighthouse	Read Replies (1) of 222

biz.yahoo.com There was some speculation a while back on how quickly Idec would get their BLA filed and accepted. Contrary to some thoughts at the time, Idec got their BLA accepted on the first go round and now trail Bexxar by mere months. We may never know the whole story on why it took Coulter's management over a year to refile thier BLA. Something still smells rank to me. Nonetheless the obvious edge in management skill goes to IDPH. I think Bexxar is a better molecule, but I wanted more breathing room between Bexxar and Zevalin. Cheers,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next